A 52-year-old man with newly diagnosed chronic myeloid leukemia (CML) in chronic phase presents to the oncology clinic. BCR-ABL mutation analysis is negative. He has no contraindications to tyrosine kinase inhibitor (TKI) therapy. What is the most appropriate next step in management?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.